Norristown, PA, United States of America

Yadong Adam Cui

This inventor holds 14 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 2 EPO patents, primarily in Polysaccharide-Protein Conjugates. Top assignees: Merck Sharp + Dohme Corp., Merck Sharp & Dohme LLC. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yadong Adam Cui. Retrieved from https://idiyas.com/inventor/yadong-adam-cui

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 9)

% Patents Active = 92.9

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 2 (Patent Applications = 7)

Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 12(Granted Patents)

Company Filing History:

13 out of 2,405

Merck Sharp + Dohme Corp.

patents

1 out of 73

Merck Sharp & Dohme LLC

patents

Years Active: 2021-2026

Loading Chart...

Areas of Expertise:

Polysaccharide-Protein Conjugates

Pneumococcal Polysaccharides

Immunogenic Compositions

Carrier Protein Conjugates

Streptococcus Pneumoniae

Methods of Use

Compositions

Vaccine Development

Biotechnology

Immunology

Antigen Design

Biopharmaceuticals

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12773448 - COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF (2026-10-27),

2. 12097250 - Compositions comprisingpolysaccharide-protein conjugates and methods of use thereof (2024-09-24),

3. 12016914 - Compositions comprisingpolysaccharide-protein conjugates and methods of use thereof (2024-06-25),

4. 11964023 - Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates (2024-04-23),

5. 11850278 - Compositions comprisingpolysaccharide-protein conjugates and methods of use thereof (2023-12-26),

6. 11759523 - Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates (2023-09-19),

7. 11759511 - Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates (2023-09-19),

8. 11759510 - Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates (2023-09-19),

9. 11642406 - Compositions comprisingpolysaccharide-protein conjugates and methods of use thereof (2023-05-09),

10. 11524076 - Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates (2022-12-13),

11. 11491216 - Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates (2022-11-08),

12. 11395849 - Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates (2022-07-26),

13. 11389540 - Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates (2022-07-19),

14. 11116828 - Compositions comprisingpolysaccharide-protein conjugates and methods of use thereof (2021-09-14),

Title: Yadong Adam Cui: Innovator in Immunogenic Compositions

Introduction

Yadong Adam Cui is a prominent inventor based in Norristown, PA (US). He has made significant contributions to the field of immunology, particularly through his innovative work on polysaccharide-protein conjugates. With a total of 13 patents to his name, Cui's inventions are paving the way for advancements in vaccine development and disease prevention.

Latest Patents

One of Yadong Adam Cui's latest patents focuses on compositions comprising polysaccharide-protein conjugates and methods of use thereof. This invention relates to multivalent immunogenic compositions that include more than one polysaccharide-protein conjugate. Each conjugate consists of a polysaccharide from anserotype conjugated to a carrier protein. The patent also outlines methods for inducing a protective immune response in human patients by administering these multivalent immunogenic compositions. These compositions are particularly useful for providing protection against infections and diseases caused by pneumococcal pathogens.

Career Highlights

Cui is currently associated with Merck Sharp & Dohme Corporation, where he continues to innovate and contribute to the field of immunology. His work is instrumental in developing new strategies for vaccine formulations that enhance patient protection against various diseases.

Collaborations

Yadong Adam Cui has collaborated with notable colleagues, including Luwy Kavuka Musey and Chitrananda Abeygunawardana. These collaborations have further enriched his research and development efforts in the field of immunogenic compositions.

Conclusion

Yadong Adam Cui's contributions to immunology through his innovative patents are significant. His work not only advances scientific understanding but also has the potential to improve public health outcomes.

Profile summary based on public USPTO records.